Myriad Genetics Inc (NASDAQ:MYGN)

34.57
Delayed Data
As of Jul 02
 +0.23 / +0.67%
Today’s Change
31.34
Today|||52-Week Range
40.50
+1.50%
Year-to-Date

Today’s Trading

Previous close34.34
Today’s open34.54
Day’s range33.84 - 34.67
Volume598,592
Average volume (3 months)772,989
Market cap$2.4B
Dividend yield--
Data as of 3:59pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+27.12%
Earnings growth (this year)-40.01%
Earnings growth (next 5 years)+13.17%
Revenue growth (last year)+26.92%
P/E ratio27.5
Price/Sales3.42
Price/Book3.53

Competitors

 Today’s
change
Today’s
% change
CXRXConcordia Healthcare...+1.22+1.69%
--COSMO Pharmaceutical...+1.20+0.75%
INSYINSYS Therapeutics I...-0.01-0.03%
TSROTESARO Inc-0.99-1.74%
Data as of 3:59pm ET, 07/02/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)$0.41
Annual revenue (last year)$778.2M
Annual profit (last year)$176.2M
Net profit margin22.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers